DANIEL TAYLOR: Open Payments
NPI 1629549407 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,456 in 95 payments from 4 companies in 2025. Trend: 2023 $13,774 · 2024 $28,632 · 2025 $22,456
Speaker / faculty: $15,495Travel & lodging: $3,836Food & beverage: $3,125
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 52 | $12,877 |
| ViiV Healthcare Company | 34 | $9,372 |
| Merck Sharp & Dohme LLC | 7 | $159 |
| Exact Sciences Corporation | 2 | $49 |
Products named: Biktarvy, DOVATO, PIFELTRO, The Cologuard Plus Collection Kit, APRETUDE, RUKOBIA.
Industry payments across CO — which companies pay providers there.
